You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

molecular subtype

Showing 1 - 25 of 5,769
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioma (Diagnosis), Liquid Biopsy, Deep Learning Trial in Wuhan, Nanchang (Prediction of glioma grading and molecular subtype)

Recruiting
  • Glioma (Diagnosis)
  • +2 more
  • Prediction of glioma grading and molecular subtype
  • Wuhan, Hubei, China
  • +1 more
Sep 8, 2022

Diffuse Large B-cell Lymphoma Trial (Rituximab, Mitoxantrone HCl liposome, Isophosphamide)

Not yet recruiting
  • Diffuse Large B-cell Lymphoma
  • (no location specified)
Mar 23, 2023

hepatoceLlular Carcinoma in Post-transplant HCC Recurrence

Recruiting
  • Hepatocellular Carcinoma Recurrent
  • Liver Transplant; Complications
  • liver transplant
  • +2 more
  • Shanghai, China
    Ren Ji Hospital, School of Medicine, Shanghai Jiao Tong Universi
Jun 21, 2021

Colon Adenocarcinoma, High-Frequency Microsatellite Instability, Metastatic Malignant Solid Tumor Trial in Houston

Active, not recruiting
  • Colon Adenocarcinoma
  • +10 more
  • Anti-PD-L1/TGFbetaRII Fusion Protein M7824
  • Houston, Texas
    M D Anderson Cancer Center
Jan 12, 2022

Shear-wave Elastography in Breast Cancer

Not yet recruiting
  • Breast Cancer
  • elastography
  • (no location specified)
Nov 3, 2023

Endometrial Adenocarcinoma Trial in Helsinki (Comparison of adjuvant therapies)

Recruiting
  • Endometrial Adenocarcinoma
  • Comparison of adjuvant therapies
  • Helsinki, Finland
    Helsinki University Hospital
Dec 8, 2022

Human Leukocyte Antigen Typing and Tumor Antigen Expression

Recruiting
  • Refractory Cancer
  • +3 more
    • Chicago, Illinois
    • +3 more
    Feb 14, 2022

    Breast Cancer Trial in Sweden (Trastuzumab deruxtecan, Docetaxel, Paclitaxel)

    Not yet recruiting
    • Breast Cancer
    • Trastuzumab deruxtecan
    • +9 more
    • Malmö, Sweden
    • +6 more
    Jun 8, 2023

    Triple-negative Breast Cancer Trial in Shanghai (Pyrotinib with Capecitabine, AR inhibitor combined with everolimus(B1) or

    Recruiting
    • Triple-negative Breast Cancer
    • Pyrotinib with Capecitabine
    • +6 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Aug 8, 2022

    Molecular Profiling Project

    Recruiting
    • Lung Cancer
    • Non-Small Cell Lung Cancer
      • Brunei, Brunei Darussalam
      • +9 more
      Oct 2, 2022

      Triple-negative Breast Cancer Trial in Shanghai (A1: SHR-A1811, A2: SHR-A1811 with Camrelizumab, B1: TROP2 ADC)

      Not yet recruiting
      • Triple-negative Breast Cancer
      • A1: SHR-A1811
      • +11 more
      • Shanghai, China
        Fudan University Shanghai Cancer Center
      Feb 19, 2023

      Endometrial Cancer in Brazil

      Not yet recruiting
      • Endometrial Cancer
      • Observational study
      • (no location specified)
      Aug 23, 2023

      Staging Endometrial caNcer Based on molEcular ClAssification

      Recruiting
      • Endometrial Cancer
      • +2 more
        • Pamplona, Navarra, Spain
          Clinica Universidad de Navarra
        Jan 30, 2023

        Breast Cancer Trial (Fluzoparib, Anastrozole, Letrozole)

        Not yet recruiting
        • Breast Cancer
        • (no location specified)
        Jun 5, 2023

        Non-muscle-invasive Bladder Cancer Trial in Shanghai (BCG combined with Tislelizumab)

        Not yet recruiting
        • Non-muscle-invasive Bladder Cancer
        • BCG combined with Tislelizumab
        • Shanghai, Shanghai, China
          Ruijin Hospital, Shanghai Jiaotong University School of Medicine
        Oct 12, 2022

        Locoregional Recurrence of Breast Cancer

        Not yet recruiting
        • Locoregional Recurrence
          • (no location specified)
          Aug 4, 2023

          comPuter Algorithm To Report BreAst cAncers (CLEOPATRAA)

          Not yet recruiting
          • Breast Cancer
          • QPlasia OncoReader Breast (QPORB)
          • Leeds, West Yorkshire, United Kingdom
            St James's University Hospital, Leeds Teaching Hospitals Trust
          Oct 26, 2023

          Multimodal Image Recognition System of Glioma Based on Deep

          Not yet recruiting
          • Glioma
          • PET/CT, H-MRS and MRI
          • (no location specified)
          Sep 7, 2021

          MRI Radiomics Combined With Pathomics on Prediction of Molecular

          Not yet recruiting
          • Endometrial Neoplasms
          • next generation sequencing AND Immunohistochemical examination
          • Fuzhou, Fujian, China
            Clinical Oncology School of Fujian Medical University, Fujian Ca
          Nov 13, 2023

          Pancreatic Cancer Trial in Milan (Fine Needle Biopsy or Aspiration)

          Recruiting
          • Pancreatic Cancer
          • Fine Needle Biopsy or Aspiration
          • Milan, Italy
            IRCCS San Raffaele Hospital
          Jul 17, 2022

          Breast Tumor Trial in Seoul (Whole breast irradiation, Whole breast and nodal irradiation)

          Active, not recruiting
          • Breast Neoplasm
          • Whole breast irradiation
          • Whole breast and nodal irradiation
          • Seoul, Korea, Republic of
            Samsung Medical Center
          Jul 10, 2022

          Estrogen Receptor Negative, HER2/Neu Negative, Progesterone Receptor Negative Trial in United States (procedure, other,

          Active, not recruiting
          • Estrogen Receptor Negative
          • +3 more
          • Dynamic Contrast-Enhanced Magnetic Resonance Imaging
          • +3 more
          • Houston, Texas
          • +5 more
          Feb 11, 2022

          Breast Cancer, Cancer of the Breast Trial in Saint Louis (VENTANA MIB-1 Ki67 assay, Oncotype DX® Recurrence Score, PAM50-based

          Not yet recruiting
          • Breast Cancer
          • Cancer of the Breast
          • VENTANA MIB-1 Ki67 assay
          • +4 more
          • Saint Louis, Missouri
            Washington University School of Medicine
          Apr 18, 2023

          Molecular Mechanism Study of Uterine Sarcoma

          Recruiting
          • Uterine Sarcoma
          • Diagnostic biomarker
          • Wuhan, Hubei, China
            Yan Li
          May 21, 2023

          Peripheral T Cell Lymphoma Trial in Shandong, Shanghai, Sichuan (84-gene penal)

          Not yet recruiting
          • Peripheral T Cell Lymphoma
          • 84-gene penal
          • Shandong, China
          • +2 more
          Jul 6, 2023